ReSure Sealant Pivotal Study
1 other identifier
interventional
488
1 country
1
Brief Summary
This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Dec 2011
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 18, 2011
CompletedFirst Posted
Study publicly available on registry
December 23, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedDecember 12, 2016
February 1, 2016
11 months
December 18, 2011
December 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of eyes with any clear corneal incision/suture leakage as determined by positive Seidel test indicating fluid egress within first 7 days after surgery.
Days 1-28
Secondary Outcomes (3)
Foreign Body Sensation
Days 1-28
Best corrected visual acuity
Day 1
Best corrected visual acuity
Day 28
Other Outcomes (5)
Presence of ReSure Sealant or suture(s)
Day 28
Presence of blue colorant in ReSure Sealant
Day 28
Device ease of use
Day 0
- +2 more other outcomes
Study Arms (2)
Suture
ACTIVE COMPARATORSuture application
ReSure Sealant
EXPERIMENTALSealant application
Interventions
Eligibility Criteria
You may qualify if:
- Subject has a cataract and is expected to undergo clear cornea cataract surgery with phacoemulsification and implantation of posterior chamber intraocular lens
- Subject must be 22 years of age or older
You may not qualify if:
- Any intraocular inflammation in study eye or presence of ocular pain in operative eye at preoperative assessment
- Previous corneal or retinal surgery or planned multiple procedures during cataract surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Levenson Eye Associates
Jacksonville, Florida, 32204, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2011
First Posted
December 23, 2011
Study Start
December 1, 2011
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
December 12, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share
Data is available on FDA website for approved PMA P130004